Two lots of Coaprovel and Karvezide, blood pressure drugs, are recalled

The Minister of Health, Carolina Darias.

The Spanish Agency for Medicines and Health Products (AEMPS) has ordered the recall of two lots of two medicines to treat blood pressure: Coaprovel and Karvezide “for not meeting quality standards.”

As reported by the AEMPS, dependent on the Ministry of Health, the recall affects batch FT028 of Coaprovel 300 mg / 25 mg with an expiration date January 31, 2023 and batch FT029 of Karvezide 300 mg / 25 mg with the same expiration date as the previous one.

In the alert note, the AEMPS has described the defect in both drugs as “detection in the active substance irbesartan of an impurity above its accepted limit” for which they are withdrawn from the market and returned to the laboratory, Sanofi Aventis, SA

The withdrawal of the drug will be monitored by the autonomous communities.


Source link